Targeting MicroRNAs With Small Molecules: From Dream to Reality

Currently, one out of four deaths in the United States is due to cancer; therefore, every major therapeutic advance in cancer has the potential to save many lives. One of the most fascinating discoveries in the area of molecular oncology in the past decade is that, in cancer, alterations in both pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2010-06, Vol.87 (6), p.754-758
Hauptverfasser: Zhang, S, Chen, L, Jung, E J, Calin, G A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 758
container_issue 6
container_start_page 754
container_title Clinical pharmacology and therapeutics
container_volume 87
creator Zhang, S
Chen, L
Jung, E J
Calin, G A
description Currently, one out of four deaths in the United States is due to cancer; therefore, every major therapeutic advance in cancer has the potential to save many lives. One of the most fascinating discoveries in the area of molecular oncology in the past decade is that, in cancer, alterations in both protein‐coding genes and noncoding RNAs, known as microRNAs (miRNAs), complement each other. In this article, we focus on a novel idea involving the use of small molecules to target overexpressed miRNAs as a new therapy for diseases, particularly cancer, in humans. Clinical Pharmacology & Therapeutics (2010) 87 6, 754–758. doi: 10.1038/clpt.2010.46
doi_str_mv 10.1038/clpt.2010.46
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1038_clpt_2010_46</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CPTCLPT201046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4316-84e2a959260bae3be16db10f384508dc1ec97693e14f15bb7684837107754ea23</originalsourceid><addsrcrecordid>eNp9kM1PwkAQxTdGI4jePJu9eLO4X91uvRhSRU1ACdZ4bLZlijVbSnZLDP-9rUW8eZq85Pdm3jyEzikZUsLVdWbW9ZCRRgp5gPrU58yTPvcPUZ8QEnoh47KHTpz7bKQIlTpGPUYEU5TSPrqNtV1CXayWeFpktpo_jxx-L-oP_FpqY_C0MpBtDLgbPLZVie8s6BLXFZ6DNkW9PUVHuTYOznZzgN7G93H06E1eHp6i0cTLBKfSUwKYDv2QSZJq4ClQuUgpybkSPlGLjEIWBjLkQEVO_TQNpBKKB5QEgS9AMz5AV93eJqNzFvJkbYtS221CSdL2kLQ9JG0PiZANftHh601awmIP_z7eAJc7QLtMm9zqVVa4P44pLhhRDRd03FdhYPvv0SSaxdFkFrfyJwLunCtdbyzsra1lh3wDp9aAEw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Targeting MicroRNAs With Small Molecules: From Dream to Reality</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Zhang, S ; Chen, L ; Jung, E J ; Calin, G A</creator><creatorcontrib>Zhang, S ; Chen, L ; Jung, E J ; Calin, G A</creatorcontrib><description>Currently, one out of four deaths in the United States is due to cancer; therefore, every major therapeutic advance in cancer has the potential to save many lives. One of the most fascinating discoveries in the area of molecular oncology in the past decade is that, in cancer, alterations in both protein‐coding genes and noncoding RNAs, known as microRNAs (miRNAs), complement each other. In this article, we focus on a novel idea involving the use of small molecules to target overexpressed miRNAs as a new therapy for diseases, particularly cancer, in humans. Clinical Pharmacology &amp; Therapeutics (2010) 87 6, 754–758. doi: 10.1038/clpt.2010.46</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/clpt.2010.46</identifier><identifier>PMID: 20428111</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Drug Delivery Systems ; Drug Design ; Gene Expression Regulation, Neoplastic - drug effects ; Humans ; Medical sciences ; MicroRNAs - antagonists &amp; inhibitors ; MicroRNAs - metabolism ; Neoplasms - drug therapy ; Neoplasms - epidemiology ; Neoplasms - genetics ; Pharmacology. Drug treatments ; United States - epidemiology</subject><ispartof>Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.754-758</ispartof><rights>2010 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4316-84e2a959260bae3be16db10f384508dc1ec97693e14f15bb7684837107754ea23</citedby><cites>FETCH-LOGICAL-c4316-84e2a959260bae3be16db10f384508dc1ec97693e14f15bb7684837107754ea23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1038%2Fclpt.2010.46$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1038%2Fclpt.2010.46$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27926,27927,45576,45577</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22834208$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20428111$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, S</creatorcontrib><creatorcontrib>Chen, L</creatorcontrib><creatorcontrib>Jung, E J</creatorcontrib><creatorcontrib>Calin, G A</creatorcontrib><title>Targeting MicroRNAs With Small Molecules: From Dream to Reality</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Currently, one out of four deaths in the United States is due to cancer; therefore, every major therapeutic advance in cancer has the potential to save many lives. One of the most fascinating discoveries in the area of molecular oncology in the past decade is that, in cancer, alterations in both protein‐coding genes and noncoding RNAs, known as microRNAs (miRNAs), complement each other. In this article, we focus on a novel idea involving the use of small molecules to target overexpressed miRNAs as a new therapy for diseases, particularly cancer, in humans. Clinical Pharmacology &amp; Therapeutics (2010) 87 6, 754–758. doi: 10.1038/clpt.2010.46</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Drug Delivery Systems</subject><subject>Drug Design</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>MicroRNAs - antagonists &amp; inhibitors</subject><subject>MicroRNAs - metabolism</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - genetics</subject><subject>Pharmacology. Drug treatments</subject><subject>United States - epidemiology</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1PwkAQxTdGI4jePJu9eLO4X91uvRhSRU1ACdZ4bLZlijVbSnZLDP-9rUW8eZq85Pdm3jyEzikZUsLVdWbW9ZCRRgp5gPrU58yTPvcPUZ8QEnoh47KHTpz7bKQIlTpGPUYEU5TSPrqNtV1CXayWeFpktpo_jxx-L-oP_FpqY_C0MpBtDLgbPLZVie8s6BLXFZ6DNkW9PUVHuTYOznZzgN7G93H06E1eHp6i0cTLBKfSUwKYDv2QSZJq4ClQuUgpybkSPlGLjEIWBjLkQEVO_TQNpBKKB5QEgS9AMz5AV93eJqNzFvJkbYtS221CSdL2kLQ9JG0PiZANftHh601awmIP_z7eAJc7QLtMm9zqVVa4P44pLhhRDRd03FdhYPvv0SSaxdFkFrfyJwLunCtdbyzsra1lh3wDp9aAEw</recordid><startdate>201006</startdate><enddate>201006</enddate><creator>Zhang, S</creator><creator>Chen, L</creator><creator>Jung, E J</creator><creator>Calin, G A</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201006</creationdate><title>Targeting MicroRNAs With Small Molecules: From Dream to Reality</title><author>Zhang, S ; Chen, L ; Jung, E J ; Calin, G A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4316-84e2a959260bae3be16db10f384508dc1ec97693e14f15bb7684837107754ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Drug Delivery Systems</topic><topic>Drug Design</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>MicroRNAs - antagonists &amp; inhibitors</topic><topic>MicroRNAs - metabolism</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - genetics</topic><topic>Pharmacology. Drug treatments</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, S</creatorcontrib><creatorcontrib>Chen, L</creatorcontrib><creatorcontrib>Jung, E J</creatorcontrib><creatorcontrib>Calin, G A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, S</au><au>Chen, L</au><au>Jung, E J</au><au>Calin, G A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting MicroRNAs With Small Molecules: From Dream to Reality</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2010-06</date><risdate>2010</risdate><volume>87</volume><issue>6</issue><spage>754</spage><epage>758</epage><pages>754-758</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><abstract>Currently, one out of four deaths in the United States is due to cancer; therefore, every major therapeutic advance in cancer has the potential to save many lives. One of the most fascinating discoveries in the area of molecular oncology in the past decade is that, in cancer, alterations in both protein‐coding genes and noncoding RNAs, known as microRNAs (miRNAs), complement each other. In this article, we focus on a novel idea involving the use of small molecules to target overexpressed miRNAs as a new therapy for diseases, particularly cancer, in humans. Clinical Pharmacology &amp; Therapeutics (2010) 87 6, 754–758. doi: 10.1038/clpt.2010.46</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>20428111</pmid><doi>10.1038/clpt.2010.46</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.754-758
issn 0009-9236
1532-6535
language eng
recordid cdi_crossref_primary_10_1038_clpt_2010_46
source Wiley-Blackwell Journals; MEDLINE
subjects Animals
Antineoplastic Agents - pharmacology
Biological and medical sciences
Drug Delivery Systems
Drug Design
Gene Expression Regulation, Neoplastic - drug effects
Humans
Medical sciences
MicroRNAs - antagonists & inhibitors
MicroRNAs - metabolism
Neoplasms - drug therapy
Neoplasms - epidemiology
Neoplasms - genetics
Pharmacology. Drug treatments
United States - epidemiology
title Targeting MicroRNAs With Small Molecules: From Dream to Reality
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T17%3A52%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20MicroRNAs%20With%20Small%20Molecules:%20From%20Dream%20to%20Reality&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Zhang,%20S&rft.date=2010-06&rft.volume=87&rft.issue=6&rft.spage=754&rft.epage=758&rft.pages=754-758&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1038/clpt.2010.46&rft_dat=%3Cwiley_cross%3ECPTCLPT201046%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20428111&rfr_iscdi=true